Healthcare News Memantine Market to Reflect Steady Growth | Page 3

REPORT DESCRIPTION
Memantine Market : Regional Analysis
North America is expected to hold dominant position in the global memantine market, owing to increasing
number of generic versions of memantine in the U.S. market. For instance, in February 2018, Lupin Limited
announced the launch of its Memantine Hydrochloride Extended-Release Capsules in the U.S. market. The
capsules are available in 7mg, 14mg, 21mg, and 28mg, for which company has received an approval from
the U.S. FDA. These are indicated for the treatment of moderate to severe dementia of the Alzheimer’s
disease.
Furthermore, Asia Pacific is expected to witness significant growth in the global memantine market, owing
to increasing focus of key players in manufacturing memantine tablets. For instance, in October 2018, Dr.
Reddy’s Laboratories launched memantine hydrochloride tablets in the Indian market. They are available in
5mg and 10mg, equivalent to generic version of Namenda tablets, which were already available in the U.S.
market in July 2015.
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2255
© Coherent market Insights. All Rights Reserved